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Protein Phosphatase 2A Positively Regulates
Ras Signaling by Dephosphorylating KSR1
and Raf-1 on Critical 14-3-3 Binding Sites
[4, 5]. Consistent with the function of MAPK scaffolds,
KSR1 interacts with the kinase components of the ERK
cascade and facilitates signal transmission from Raf-1
to MEK and ERK (reviewed in [6]). Moreover, recent
studies using RNA interference to investigate Drosophila
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for Ras-mediated ERK pathway activation [5, 7, 8].SAIC-Frederick
Frederick, Maryland 21702 The physiological relevance of scaffolding proteins to
MAPK activation was initially demonstrated in yeast,
where Ste5 was shown to be required for activation of
the MAPK module involved in pheromone mating [9, 10].Summary
Although a structural homolog of Ste5 has not been
found in mammalian cells, proteins have been identifiedBackground: Kinase Suppressor of Ras (KSR) is a con-
that perform scaffolding functions for the ERK, JNK,served component of the Ras pathway that acts as a
and p38 MAPK cascades [11–13]. Strikingly, a generalmolecular scaffold to facilitate signal transmission through
feature that has emerged from studies of these scaffold-the MAPK cascade. Although recruitment of KSR1 from
ing proteins is their involvement in the spatiotemporalthe cytosol to the plasma membrane is required for its
regulation of MAPK activity. For example, JNK-inter-scaffolding function, the precise mechanism(s) regulat-
acting protein (JIP) scaffolds can direct JNK compo-ing the translocation of KSR1 have not been fully eluci-
nents to specific subcellular regions of specialized cells,dated.
such as growth cones of neurons, due to their abilityResults: Using mass spectrometry to analyze the KSR1-
to be dynamically redistributed within cells by kinesinscaffolding complex, we identify the serine/threonine
motor proteins [14]. In addition, the -arrestins, whichprotein phosphatase PP2A as a KSR1-associated pro-
function as ERK and JNK3 scaffolds in G protein-cou-tein and show that PP2A is a critical regulator of KSR1
pled receptor pathways, retain active ERK and JNK3 inactivity. We find that the enzymatic core subunits of
the cytoplasm, thereby restricting their activity to cyto-PP2A (PR65A and catalytic C) constitutively associate
plasmic substrates [15]. Another ERK scaffold, Mekwith the N-terminal domain of KSR1, whereas binding
partner 1 (MP1), localizes to late endosomes via an inter-of the regulatory PR55B subunit is induced by growth
action with the p14 adaptor protein and plays a special-factor treatment. Specific inhibition of PP2A activity pre-
ized role in ERK1 activation at this site [16]. Significantly,vents the growth factor-induced dephosphorylation
ectopic targeting of the MP1/p14 complex to the plasmaevent involved in the membrane recruitment of KSR1
membrane prevents MP1-mediated augmentation ofand blocks the activation of KSR1-associated MEK and
ERK signaling. Thus, uncovering the mechanisms thatERK. Moreover, we find that PP2A activity is required
regulate the intracellular localization of different scaf-for activation of the Raf-1 kinase and that both Raf and
folding proteins is critical for understanding their func-KSR1 must be dephosphorylated by PP2A on critical
tion in MAPK activation.regulatory 14-3-3 binding sites for KSR1 to promote
For the mammalian KSR1 scaffold, its intracellularMAPK pathway activation.
localization is dynamic and changes in response to RasConclusions: These findings identify KSR1 as novel
activation events. In quiescent cells, KSR1 is found in thesubstrate of PP2A and demonstrate the inducible de-
cytosol, where it constitutively associates with MEK, 14-phosphorylation of KSR1 in response to Ras pathway
3-3 proteins, and Cdc25C-associated kinase 1 (C-TAK1)activation. Further, these results elucidate a common
[4, 17, 18]. Dimers of 14-3-3 bind to two serine phosphor-regulatory mechanism for KSR1 and Raf-1 whereby their
ylated residues, S297 and S392, and this interaction islocalization and activity are modulated by the PP2A-
critical for retaining KSR1 in the cytoplasm [4]. In re-mediated dephosphorylation of critical 14-3-3 binding
sponse to signal activation, S392 becomes dephosphor-sites.
ylated, releasing 14-3-3 and allowing the KSR1 complex
to rapidly translocate to the plasma membrane [4]. The
Introduction S392/14-3-3 binding site is in close proximity to the
KSR1 cysteine-rich C1 domain, and mutational analysis
Kinase Suppressor of Ras (KSR) was first identified by indicates that the C1 domain is required for the translo-
genetic studies in Drosophila melanogaster and Caeno- cation of KSR1 to the plasma membrane [19]. Therefore,
rhabditis elegans, where it was found to be a positive it is likely that release of 14-3-3 from the S392 site expo-
effector of Ras signaling [1–3]. Although the presence ses this region, thereby facilitating membrane localiza-
of a kinase-like domain led to initial speculation that tion. In addition, KSR1 proteins mutated at S392 display
KSR1 might function as a protein kinase, data now indi- stronger binding to ERK [4], indicating that release of
cate that KSR1 does not possess intrinsic kinase activity 14-3-3 may also expose the FxFP motif required for
and instead acts as a MAPK scaffold for the Ras pathway ERK binding [20]. Thus, when Ras is activated, KSR1
localizes MEK with activated Raf-1 at the plasma mem-
brane, provides a docking platform for ERK, and facili-*Correspondence: dmorrison@ncifcrf.gov
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Figure 1. Identification of PP2A as a KSR1-
Associated Protein
(A) Wild-type KSR1 complexes isolated from
growing Cos cells were resolved by SDS-
PAGE and stained with Coomassie brilliant
blue. The control sample was prepared from
untransfected cell lysates. Several KSR1-
associated proteins detected in this analysis
are indicated.
(B) Shown are peptide sequences of the PP2A
PR65A, PR55B, and catalytic C subunits
identified by MALDI-TOF and MS/MS analysis.
tates the sequential phosphorylation events required for proteins with molecular masses of 65, 55, and 36 kDa
revealed peptides from three subunits of the serine/ERK activation.
Recent studies have revealed that C-TAK1 is the ki- threonine phosphatase PP2A, namely the PR65/A,
PR55/B, and catalytic/C subunits, respectively (Fig-nase that phosphorylates KSR1 on S392 in quiescent
cells [4]. However, the molecular mechanisms responsi- ure 1B). It should be noted that no PP2A peptides were
detected in control samples prepared from untrans-ble for the inductive dephosphorylation of the KSR1
S392 site have not been elucidated. In this study, we fected cells and that PP2A was the only phosphatase
identified in the KSR1 complexes. PP2A is a heterotri-show that the protein phosphatase PP2A is a compo-
nent of the KSR1 scaffolding complex and find that PP2A meric protein composed of a dimeric core enzyme (the
structural A and the catalytic C subunits) and a regula-activity is required for the stimulus-induced dephos-
phorylation of S392. Moreover, our results indicate that tory subunit (B-type subunits) (reviewed in [23]). Thus,
the entire PP2A holoenzyme is detected in KSR1 com-dephosphorylation of both KSR1 and the Raf-1 kinase
by PP2A is needed for KSR1-mediated MAPK activation. plexes isolated from cycling cells.
These findings demonstrate the importance of PP2A as
a regulator of Ras signaling. Growth Factor Treatment Induces Interactions
between PP2A and KSR1
To confirm the KSR1/PP2A interaction and to localizeResults
the region of KSR1 required for PP2A binding, various
KSR-1 deletion mutants were tested for their ability toPP2A Is a Component of the KSR1 Complex
KSR1 has been shown to be part of a high molecular associate with the A, B, and C subunits of PP2A. For
this analysis, the KSR1 proteins were expressed in cy-weight complex (300–500 kDa) in mammalian cells [21,
22]. To further characterize this complex and to isolate cling Cos cells and lysates were prepared under more
stringent lysis conditions using buffers containing 1%potential regulators of KSR1 function, we used mass
spectrometry to identify the proteins associating with NP-40. Subsequent examination of the KSR1 complexes
revealed that all three PP2A subunits were present inthe KSR1 scaffold. Pyo-tagged KSR1 proteins were ex-
pressed in cycling Cos cells, and extracts were prepared immunoprecipitates of the N-terminal N539, N424, and
N320 KSR1 proteins, but not in samples containing theusing a lysis buffer optimized to maintain protein interac-
tions (0.2% Triton X-100 lysis buffer). The KSR1 com- N-terminal N249 mutant or the C-terminal C542 protein
(Figure 2A). These findings confirm the mass spectrome-plexes were then isolated using covalently coupled anti-
Pyo affinity beads. The complexes were separated by try analysis and localize the binding site for PP2A to
residues 249–320 of KSR1.one-dimensional SDS-PAGE and visualized by Coomas-
sie blue staining (Figure 1A). Proteins were extracted Because the above experiments were conducted with
cycling cells, they do not distinguish whether the inter-from the gel matrix by trypsin digestion and analyzed
by ion trap mass spectrometry. Using this approach, we action of the PP2A subunits with KSR1 is constitutive
or inducible. To address this issue, we examined theidentified peptides from several known KSR1-inter-
acting proteins, including Hsp90, Hsp70, p50/Cdc37, effects of serum starvation and growth factor treatment
on the KSR1/PP2A interaction. NIH3T3 cells were in-MEK1, MEK2, ERK1, ERK2, C-TAK1, and 14-3-3 [6, 21];
however, no peptides from the Raf family of kinases fected with a recombinant adenovirus expressing wild-
type (wt) KSR1. KSR1 complexes were then isolatedwere obtained. In addition, analysis of KSR1-associated
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not change upon growth factor addition. In contrast,
binding of the regulatory B subunit was dramatically
increased by PDGF treatment. These data indicate that
the PP2A core enzyme is a constitutive component of
the KSR1 complex, whereas the regulatory B subunit
interaction is induced by Ras pathway activation.
To investigate the biological relevance of the KSR1/
PP2A interaction, the association of endogenous KSR1
and PP2A proteins was examined. KSR1 immunoprecip-
itates were prepared from mouse brain, a tissue that
expresses high levels of both KSR1 and PP2A and where
endogenous complex formation between KSR1, MEK,
MAPK, C-TAK1, and 14-3-3 has been demonstrated [4].
The A and C core subunits were readily detected in the
KSR1 immunoprecipitates from brain lysates, but much
lower levels of the B subunit were observed (Figure 2C
and data not shown). The weak detection of the B sub-
unit is consistent with the idea that the B subunit interac-
tion is inducible and therefore would not be expected
to occur in all cells; however, it could also indicate that
other B-type subunits associate with KSR1 in brain tis-
sue. Nonetheless, these findings demonstrate the en-
dogenous interaction of KSR1 with the PP2A catalytic
core subunits in a biologically relevant setting.
In Vivo Dephosphorylation of S392 and Membrane
Targeting of KSR1 Require PP2A Activity
In light of the inducible interaction of the PP2A regulatory
B subunit with KSR1, we investigated whether PP2A is
responsible for the growth factor-induced dephosphor-
ylation of the KSR1 S392 site. For these experiments,
KSR1-expressing NIH3T3 cells were metabolically la-
beled with [32P]orthophosphate and treated or not with
PDGF prior to lysis. Labeled KSR1 was isolated, di-
gested with trypsin, and analyzed by high-pressure liq-
uid chromatography (HPLC; Figure 3A). As previously
reported [4, 17, 24], we found that both S297 and S392
(fraction 7 and 22 eluates, respectively) were highly
phosphorylated in quiescent cells and that PDGF treat-
ment triggered the dephosphorylation of S392 but not
S297. To determine whether PP2A activity is required
for S392 dephosphorylation, cells were treated with the
phosphatase inhibitor, okadaic acid (OA), under condi-
tions previously shown to inhibit PP2A but not other OA-Figure 2. Analysis of the KSR1/PP2A Interaction
sensitive phosphatases, such as protein phosphatase(A) N539, N424, N320, N249, and C542 KSR1 proteins were im-
1(PP1; [25]). Strikingly, in cells treated with OA prior tomunoprecipated from lysates of transfected Cos cells using the anti-
PDGF stimulation, the phosphorylation state of S392 didPyo affinity beads. The immune complexes were then examined by
immunoblot analysis using antibodies recognizing the A, B, and not decrease and was even higher than that observed
catalytic C subunits of PP2A as well as the Pyo-tag. Total cell lysates in quiescent cells (Figure 3A). OA treatment had no effect
were included as a control to identify the position of the PP2A on the phosphorylation state of S297 or on the growth
subunits.
factor-induced phosphorylation of KSR1 peptides elut-(B) Serum-starved NIH3T3 cells infected with a recombinant adeno-
ing in HPLC fractions 34–36 (Figure 3A). Thus, specificvirus expressing wt KSR1 were left untreated or were treated with
inhibition of PP2A activity selectively alters the phos-PDGF for 5 and 15 min. KSR1 immunoprecipitates were prepared
and examined as in (A). phorylation state of S392.
(C) Endogenous KSR1 was immunoprecipitated from mouse brain Due to the critical role of S392 phosphorylation in
lysates and examined as in (A). Lysate incubated with ProteinA/G KSR1 membrane targeting, we assessed the require-
beads alone was included as a control.
ment of PP2A activity for the growth factor-induced
membrane localization of KSR1. For these assays, the
subcellular localization of KSR1 was determined by indi-from lysates of serum-starved cells that had been
treated with platelet-derived growth factor (PDGF) or rect immunofluorescent staining. As shown in Figure
3B, wt KSR1 was detected exclusively in the cytosol ofleft untreated. As shown in Figure 2B, both the A and
C core subunits were detected in KSR1 immunoprecipi- quiescent cells; however, treatment with PDGF induced
the rapid translocation of wt KSR1 to plasma membranetates from serum-starved cells and their association did
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Figure 3. Effect of PP2A Inhibition on the
Phosphorylation State, Subcellular Localiza-
tion, and MAPK Scaffolding Function of KSR1
(A) NIH3T3 cells expressing wt or S392A
KSR1 were labeled in vivo with [32P]ortho-
phosphate. Untreated or OA-treated cells
were then stimulated with PDGF for 5 min
prior to lysis. Tryptic phosphopeptides iso-
lated from the labeled KSR1 proteins were
separated by HPLC. Shown are the profiles of
radioactivity collected in the HPLC fractions.
Labeled peptides containing the S297 and
S392 phosphorylation sites are indicated.
(B) NIH3T3 cells expressing wt or S392A KSR1
were treated with okadaic acid and PDGF as
in (A). The subcellular localization of the KSR1
proteins was then determined by indirect im-
munofluorescence using the Pyo antibody.
(C) Serum-starved NIH3T3 cells expressing
wt KSR1 were either left untreated or were
treated with OA prior to PDGF stimulation.
KSR1 proteins were immunoprecipitated
from cell lysates using the anti-Pyo affinity
beads and the immune complexes examined
by immunoblot analysis using phospho-MEK
(P-MEK, top left), total MEK (bottom left), pan-
ERK (top right), and phospho-ERK antibodies
(middle right). Total cell lysates were also
probed with pan-ERK antibody (bottom right).
ruffles (Figure 3B). KSR1 proteins mutated at the S392 cell membrane appears to expose the MAPK binding
site on KSR1 [4]. These events also serve to colocalizesite were localized constitutively at the plasma mem-
brane even in serum-starved cells. Strikingly, treatment MEK and ERK with activated Raf-1 at the plasma mem-
brane, thereby facilitating MEK and ERK activation. Toof cells with OA prior to PDGF stimulation prevented the
localization of wt KSR1 to the plasma membrane ruffles gain further insight into how PP2A activity affects MAPK
signaling via KSR1, we investigated whether activationbut had no effect on the translocation of S392A KSR1.
of KSR1-associated MEK and ERK were dependent on
PP2A activity. Serum-starved wt KSR1-expressing NIH3T3PP2A Activity Is Required for Activation
of KSR1-Associated MEK and MAPK cells were left untreated or were treated with OA prior
to growth factor stimulation. KSR1 complexes were iso-The release of 14-3-3 from the KSR1 S392 site and the
subsequent translocation of the KSR1 complex to the lated and examined using antibodies that specifically
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recognize the activated phosphorylated forms of MEK
and ERK (P-MEK or P-ERK), as well as those recognizing
total MEK and ERK levels. As shown in Figure 3C, the
overall level of KSR1-associated MEK did not vary with
PDGF treatment; however, activated MEK was only de-
tected in KSR1 immunoprecipitates after PDGF addi-
tion. When PP2A activity was inhibited by OA prior to
PDGF treatment, the total level of KSR1-associated MEK
remained unaltered, whereas detection of activated
MEK in KSR1 complexes was nearly abolished. As pre-
viously observed, growth factor stimulation was re-
quired for the binding of ERK to KSR1 and for the detec-
tion of activated ERK in the KSR1 samples (Figure 3C).
Treatment with OA disrupted the interaction between
KSR1 and ERK, such that little or no activated ERK
was detected in the complexes. Thus, PP2A inhibition
disrupts the activation of KSR1-associated MEK and
ERK, consistent with the findings that this inhibition also
blocks S392 dephosphorylation and KSR1 membrane
localization.
Dephosphorylation of Both KSR1 and Raf-1
by PP2A Is Required for KSR1-Mediated MAPK
Pathway Activation
The dimeric core subunits of PP2A have also been re-
ported to interact with Raf-1, and studies indicate that
PP2A contributes to Raf-1 activation by dephosphory-
lating S259, a negative regulatory site on Raf-1 that
confers 14-3-3 binding [26–28]. In addition, these reports
showed that although PP2A inhibition blocked activa-
tion of wt Raf-1, it had little effect on Raf-1 mutated at
the S259 site. Therefore, it is possible that the lack of
activated MEK in KSR1 complexes isolated from OA-
treated cells could be due to Raf-1 inhibition rather than
a defect in KSR1 membrane localization. First, to confirm
the importance of PP2A to Raf-1 signaling in our system,
Pyo-tagged Raf-1 complexes were isolated from cycling
Cos cells and examined for the presence of PP2A by
mass spectrometry. As was observed for KSR1 com-
plexes, peptides from the PR65/A, PR55/B, and cata-
lytic/C subunits of PP2A were detected in the Raf-1
Figure 4. PP2A Associates with Raf-1 and Is a Regulator of Raf-1
samples (Figure 4A). Examination of the PP2A/Raf-1 in- Phosphorylation
teraction by immunoblot analysis further revealed that,
(A) Pyo-Raf-1 complexes isolated from growing Cos cells were ana-
like KSR1, the association of the dimeric core subunits lyzed by mass spectrometry as described in Figure 1. Shown are
(A and C) was constitutive, whereas binding of the regu- peptide sequences of the PP2A PR65A, PR55B, and catalytic C
subunits identified in the Raf-1 complexes.latory B subunit was significantly induced by growth
(B) Serum-starved NIH3T3 cells expressing wt Raf-1 were left un-factor treatment (Figure 4B). Moreover, using antibodies
treated or were treated with PDGF for 5 and 15 min. Raf-1 complexesthat recognize Raf-1 phosphorylated at S259, we con-
were isolated using the anti-Pyo affinity beads and examined byfirmed that PP2A activity is required for the growth fac-
immunoblot analysis using antibodies recognizing the A, B, and
tor-induced dephosphorylation of S259 (Figure 4C). catalytic C subunits of PP2A.
To investigate whether the OA-induced block in (C) NIH3T3 cells expressing wt Raf-1 were left untreated or were
treated with OA prior to EGF treatment and lysis. Raf-1 proteinsKSR1-mediated MAPK pathway activation involves
were immunoprecipitated and examined by immunoblot analysisRaf-1, NIH3T3 cells were transfected with plasmids en-
using antibodies recognizing Raf-1 phosphorylated on S259coding Flag-tagged Raf-1 and Pyo-tagged KSR1 pro-
(P-S259) or total Raf-1.teins that were either wild-type (wt) or that contained
mutations in the sites dephosphorylated by PP2A
(S259A Raf-1 and S392A KSR1). Serum-starved cells
were left untreated or were treated with OA prior to
PDGF stimulation. The Flag-Raf-1 proteins were then Consistent with previous results [26], OA treatment pre-
vented the PDGF-induced activation of wt Raf-1 but hadisolated and assayed for enzymatic activity, while the
Pyo-KSR1 proteins were examined for the level of KSR1- minimal effect on S259A Raf-1 activation. Under these
conditions, however, no phospho-MEK or phospho-ERKassociated phospho-MEK and phospho-ERK (Figure 5).
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Figure 5. PP2A Activity Is Required for
KSR1-Associated MEK Activation
Flag-tagged wt Raf-1 or S259A Raf-1 were
coexpressed in NIH3T3 cells with either Pyo-
tagged wt KSR1 or S392A KSR1. Serum-
starved cells were left untreated or were
treated with OA for 55 min prior to PDGF stim-
ulation for 5 min. For Raf-1 activity measure-
ments (top graph), Raf-1 proteins were immu-
noprecipitated with the Flag antibody, and
in vitro kinase assays were performed using
kinase-inactive MEK as a substrate. Kinase
activity is expressed as fold activation rela-
tive to wt Raf-1 cotransfected with wt KSR1
in nontreated cells. It should be noted that
the coexpression of KSR1 and Raf-1 did not
significantly alter the activity of the Raf-1 pro-
teins. For coimmunoprecipitation experiments,
KSR1 proteins were immunoprecipitated us-
ing the anti-Pyo affinity beads and examined
by immunoblot analysis using phospho-MEK
(P-MEK), total MEK, and phospho-ERK
(P-ERK) antibodies. Lysates were probed for
the presence of both KSR1 and Raf-1 to eval-
uate the relative expression level of each
protein.
was detected in wt KSR1 complexes isolated from cells subunits constitutively interact forming a core complex,
to which one of several B subunits can bind. Binding ofcoexpressing either wt or S259A Raf-1, indicating that
when PP2A activity is inhibited, Raf-1 activation alone B-type subunits increases enzymatic activity and can
modulate the subcellular localization and substrateis insufficient to promote phosphorylation of wt KSR1-
associated MEK and ERK. In contrast, complexes of specificity of the holoenzyme. In addition, PP2A activity
can be further regulated by posttranslational modifica-S392A KSR1, the mutant exhibiting constitutive mem-
brane localization, did contain activated MEK and ERK, tions to the catalytic C subunit and by the binding of
inhibitory proteins and other viral or cellular cofactors.but only when isolated from cells coexpressing S259A
Raf-1. These results show that both the membrane local- Using mass spectrometry, here we report that the
PR65/A, PR55/B, and catalytic/C subunits of PP2A areization of KSR1 and the activation of Raf-1 are required
for KSR1 to promote Ras-dependent activation of MEK present in KSR1 complexes isolated from cycling cells.
Coimmunoprecipitation assays confirmed this interac-and ERK.
tion and demonstrated the association of endogenous
PP2A and KSR1 in murine brain. Although it is unclearDiscussion
whether this interaction is direct, residues 249–320 of
the KSR1 N-terminal domain were found to be requiredA key feature of mammalian MAPK scaffolding proteins
is their ability to regulate the spatiotemporal activation for the association of all three PP2A subunits. Further
characterization of these interactions revealed thatof MAPK components. For KSR1, its scaffolding function
requires that it be translocated from the cytosol to the while the binding of the dimeric core complex was con-
stitutive, the interaction between KSR1 and the PP2Aplasma membrane, an event regulated by dephosphory-
lation of a critical 14-3-3 binding site—S392. In this re- regulatory B subunit increased dramatically following
Ras pathway activation. The underlying mechanism(s)port, we identify PP2A as a component of the KSR1
complex and find that PP2A mediates the dephosphory- for why binding of the B subunit is induced by growth
factor treatment are currently unknown; however, incor-lation of S392. Our findings provide new insight into the
regulation of KSR1 function and further elucidate the poration of the B subunit into the complex would be
expected to increase the catalytic activity of PP2A to-molecular mechanisms whereby PP2A contributes to
Ras/MAPK signal transduction. ward KSR1.
Indeed, we do find that KSR1 is a substrate of PP2APP2A is an essential serine/threonine phosphatase
found in all eukaryotic organisms. It is a heterotrimeric and that PP2A activity is required for the dephosphoryla-
tion event mediating the membrane recruitment ofenzyme that consists of a structural A, catalytic C, and
regulatory B subunits (reviewed in [23]). The A and C KSR1. Despite its constitutive association with the PP2A
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Figure 6. Model for the Role of PP2A as a
Positive Effector of Ras Signaling
(A) In quiescent cells, KSR1 and Raf-1 are
localized in the cytoplasm and constitutively
interact with 14-3-3 dimers and the core sub-
units of PP2A (A and C subunits). The 14-3-3
dimer is bound to the S297 and S392 phos-
phorylation sites of KSR1 and to the S259
and S621 phosphorylation sites of Raf-1. In
addition, MEK and C-TAK1 are constitutive
components of the KSR1 complex.
(B) In stimulated cells, Ras activation induces
binding of the PP2A regulatory B subunit to
the KSR1 and Raf-1 complexes, increasing
PP2A activity and resulting in the dephos-
phorylation of KSR1 on S392 and Raf-1 on
S259. These dephosphorylation events con-
tribute to the plasma membrane targeting of
both proteins. For Raf-1, S259 dephosphory-
lation and 14-3-3 release has been reported
to facilitate the Ras/Raf interaction mediated
by the Ras binding domain (RBD) of Raf-1.
For KSR1, S392 dephosphorylation and
14-3-3 release appears to expose the C1 do-
main, which is required for the membrane localization of KSR1, as well as the FxFP MAPK binding site. Whether all the PP2A subunits
translocate to the membrane with KSR1 and Raf-1 is currently unknown. At the membrane, Raf-1 is activated and KSR1 provides a platform
for the phosphorylation/activation of associated MEK and ERK.
core enzyme, which has been shown to possess phos- action, binding of the PP2A regulatory B subunit is in-
duced by growth factor treatment. Strikingly, we foundphatase activity in vitro, KSR1 remains highly phosphor-
ylated on S392 and S297 in quiescent cells. Both of that when PP2A was inhibited, activation of KSR1-asso-
ciated MEK and ERK was only observed if both KSR1these sites mediate binding to 14-3-3, and as a result,
14-3-3 binding may protect these residues from dephos- and Raf were mutated at their respective PP2A substrate
sites. Our studies thus reveal a dual role for PP2A inphorylation. Interestingly, the kinase that phosphory-
lates the S392 site, C-TAK1, also associates constitu- Raf-1 activation and KSR1 scaffold relocalization, both
of which are essential for KSR1 to promote Ras-depen-tively with KSR1 [4]. Thus, in quiescent cells, there may
be a constant cycling between S392 phosphorylation/ dent activation of MEK and ERK (Figure 6).
Biochemical and genetic studies have previously im-14-3-3 binding and S392 dephosphorylation/14-3-3 re-
lease that remains at equilibrium due to the opposing plicated PP2A in the regulation of Ras signaling. In par-
ticular, mutations in PP2A subunit genes have been re-activities of C-TAK1 and the PP2A core complex. When
cells are treated with growth factors, the increased covered in Drosophila and C. elegans genetic screens
for components of the Ras pathway [29, 30]. Forphosphatase activity due to B subunit binding would
then drive the equilibrium toward S392 dephosphoryla- C. elegans, PP2A was identified as positive effector of
Ras signaling, while in Drosophila, PP2A was found totion. In support of this model, we found that inhibition
of PP2A not only blocked the growth factor-induced have both positive and negative effects on the Ras path-
way. These differences presumably reflect the multiplic-dephosphorylation of S392 but led to increased phos-
phate incorporation at this site. ity of targets that are affected by loss of PP2A activity.
For example, MEK and ERK are likely candidates for theThe findings that PP2A activity is required for the
membrane translocation of KSR1 demonstrate a com- inhibitory effect of PP2A, given that both kinases can
be dephosphorylated and inactivated by PP2A in vitromon regulatory mechanism for Raf-1 and KSR1,
whereby dephosphorylation of a critical 14-3-3 binding [31, 32] and that inhibition of PP2A leads to MEK and
ERK activation in vivo [31, 33–35]. In flies and worms,site contributes to the membrane targeting of both pro-
epistasis experiments suggest that the unknown mole-teins. The translocation of the Raf-1 kinase to the plasma
cule(s) positively affected by PP2A function downstreammembrane and its subsequent activation depends upon
of Ras and upstream of or in parallel to Raf. Our findingsmultiple parameters, including GTP loading of Ras, inter-
that PP2A is a component of the KSR1 scaffolding com-actions with lipid cofactors, phosphorylation events,
plex and that both KSR1 and Raf-1 are positively regu-and 14-3-3 binding. Dephosphorylation of Raf at S259
lated by PP2A are consistent with these genetic infer-promotes its membrane recruitment and activation, due
ences. Moreover, our findings that PP2A activity isapparently to an increased binding affinity for activated
required for KSR1 to promote ERK pathway activationRas [27, 28]. The dimeric core subunits of PP2A have
defines a biochemical mechanism for how PP2A canbeen reported to interact with Raf-1 [26], and PP2A has
function as a positive effector of Ras signaling.been implicated in the dephosphorylation of Raf-1 at
S259 [26, 27]. In our studies, we find that the PP2A core
Experimental Proceduressubunits as well as the regulatory B subunit can be
detected by mass spectrometry in Raf-1 complexes iso- Antibodies and Reagents
lated from growing cells. Further analysis of the PP2A/ Antibodies recognizing the polyoma tag (Pyo) and KSR1 have been
previously described [17, 36]. The phospho-MEK and phospho-Raf-1 interaction revealed that like the PP2A/KSR1 inter-
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MAPK antibodies were purchased from Cell Signaling Technology; by the addition of gel sample buffer. Proteins were resolved by SDS-
PAGE and transferred to nitrocellulose. The radioactivity incorpo-the MEK, ERK, and PP2A-C antibodies from Transduction Labora-
tories; PP2A-A and PP2A-B antibodies from Santa Cruz Biotechnol- rated into MEK, as well as the amount of Raf-1 protein immunopre-
cipitated, was then quantified.ogy; and the Flag antibody from Sigma. PDGF and okadaic acid
were obtained from Upstate Biotechnology and EGF was purchased
from Invitrogen. Acknowledgments
DNA Constructs, Cell Culture, and Transfection We thank D. Ritt for excellent technical assistance and M. Fortini
pcDNA3 constructs encoding Pyo-tagged wt and mutant KSR1 pro- and members of the Morrison laboratory for critical reading of the
teins have been previously described [4]. Generation of the pcDNA3 manuscript and helpful discussions. This project has been funded
Flag-tagged wt and S259A Raf-1 constructs is reported in [37]. in whole or in part with federal funds from the National Cancer
Cos and NIH3T3 cells were cultured in Dulbecco’s modified Eagle’s Institute, National Institutes of Health, under Contract No. NO1-CO-
medium (DMEM) supplemented with 10% fetal calf serum at 37C 12400. The content of this publication does not necessarily reflect
in 5% CO2. Plasmid DNAs were transfected into Cos cells using the the views or policies of the Department of Health and Human Ser-
Fugene reagent (Roche) and into NIH3T3 cells using Lipofectamine vices, nor does mention of trade names, commercial products, or
(Invitrogen). organizations imply endorsement by the US Government.
Isolation of KSR1 Complexes and Mass Received: May 6, 2003
Spectrometry Analysis Revised: June 16, 2003
Cycling Cos cells expressing wt KSR1 were lysed in Triton X-100 Accepted: June 17, 2003
lysis buffer (20 mM Tris [pH 8.0], 137 mM NaCl, 10% glycerol, 0.2% Published: August 19, 2003
Triton X-100, 0.15 U/ml aprotinin, 1 mM PMSF, 20 M leupeptin,
5 mM sodium vanadate) for 20 min on ice. Lysates were cleared of
References
insoluble material by centrifugation at 4C for 20 min at 16,000 
g, and the Pyo-tagged KSR1 proteins were immunoprecipitated 1. Kornfeld, K., Hom, D.B., and Horvitz, H.R. (1995). The ksr-1
using covalently coupled anti-Pyo sepharose beads. Immune com- gene encodes a novel protein kinase involved in Ras-mediated
plexes were washed three times with lysis buffer and then examined signaling in C. elegans. Cell 83, 903–913.
by SDS-PAGE and Coomassie brilliant blue staining (BioRad). Pro- 2. Sundaram, M., and Han, M. (1995). The C. elegans ksr-1 gene
tein gel bands were digested with trypsin and the peptides extracted encodes a novel Raf-related kinase involved in Ras-mediated
as described in [38]. The samples were desalted with C18 Zip Tips signal transduction. Cell 83, 889–901.
(Millipore) prior to analysis by microcapillary reversed-phase liquid 3. Therrien, M., Chang, H.C., Solomon, N.M., Karim, F.D., Wassar-
chromatography using an Agilent 1100 capillary LC system (Agilent man, D.A., and Rubin, G.M. (1995). KSR, a novel protein kinase
Technologies, Inc.) coupled online to an ion trap (IT) mass spectrom- required for RAS signal transduction. Cell 83, 879–888.
eter (LCQ Deca XP, Thermo Finnigan). Reversed-phase separations 4. Muller, J., Ory, S., Copeland, T., Piwnica-Worms, H., and Mor-
were performed using 75 m i.d.  360 m o.d.  10 cm long rison, D.K. (2001). C-TAK1 regulates Ras signaling by phosphor-
capillary columns (Polymicro Technologies, Inc.) that were slurry ylating the MAPK scaffold, KSR1. Mol. Cell 8, 983–993.
packed in-house with 5 m Jupiter C-18 stationary phase (Pheno- 5. Roy, F., Laberge, G., Douziech, M., Ferland-McCollough, D.,
menex). After sample injection, a 20 min wash with 95% buffer A and Therrien, M. (2002). KSR is a scaffold required for activation
(0.1% v/v formic acid in water) was applied and peptides were eluted of the ERK/MAPK module. Genes Dev. 16, 427–438.
using a linear gradient of 5% solvent B (0.1% v/v formic acid in 6. Morrison, D.K. (2001). KSR: a MAPK scaffold of the Ras path-
acetonitrile) to 45% solvent B over 40 min with a constant flow rate way? J. Cell Sci. 114, 1609–1612.
of 0.5 l/min. The IT-MS was operated in a data-dependent mode 7. Anselmo, A.N., Bumeister, R., Thomas, J.M., and White, M.A.
where each full MS scan was followed by three tandem MS scans (2002). Critical contribution of linker proteins to Raf kinase acti-
in which the three most abundant peptide molecular ions were dy- vation. J. Biol. Chem. 277, 5940–5943.
namically selected for collision-induced dissociation (CID) using a 8. Ohmachi, M., Rocheleau, C.E., Church, D., Lambie, E., Schedl,
normalized collision energy of 38%. The temperature of heated cap- T., and Sundaram, M.V. (2002). C. elegans ksr-1 and ksr-2 have
illary and electrospray voltage (applied on column base) was 180C both unique and redundant functions and are required for
and 1.8 kV, respectively. The CID spectra were searched against MPK-1 ERK phosphorylation. Curr. Biol. 12, 427–433.
the NCBI nonredundant protein database using SEQUEST (Thermo 9. Choi, K.Y., Satterberg, B., Lyons, D.M., and Elion, E.A. (1994).
Finnigan). Ste5 tethers multiple protein kinases in the MAP kinase cascade
required for mating in S. cerevisiae. Cell 78, 499–512.
Coimmunoprecipitation Assays, Metabolic Labeling, 10. Elion, E.A. (2001). The Ste5p scaffold. J. Cell Sci. 114, 3967–
and Indirect Immunofluorescence 3978.
Transfected Cos cells or NIH3T3 cells infected with a KSR1-express- 11. Whitmarsh, A.J., and Davis, R.J. (1998). Structural organization
ing recombinant adenovirus [4] were either incubated for 48 hr in of MAP-kinase signaling modules by scaffold proteins in yeast
fully supplemented medium or were serum starved for 24 hr prior and mammals. Trends Biochem. Sci. 23, 481–485.
to growth factor addition. When indicated, serum-starved cells were 12. Karandikar, M., and Cobb, M.H. (1999). Scaffolding and protein
treated for 55 min with 0.5 M okadaic acid prior to growth factor interactions in MAP kinase modules. Cell Calcium 26, 219–226.
treatment. Cells were then lysed in NP-40 lysis buffer (20 mM Tris 13. Garrington, T.P., and Johnson, G.L. (1999). Organization and
[pH 8.0], 137 mM NaCl, 10% glycerol, 1% NP-40, 0.15 U/ml aprotinin, regulation of mitogen-activated protein kinase signaling path-
1 mM PMSF, 20 M leupeptin, 5 mM sodium vanadate), and the ways. Curr. Opin. Cell Biol. 11, 211–218.
KSR1 proteins were immunoprecipitated. After four washes in lysis 14. Verhey, K.J., Meyer, D., Deehan, R., Blenis, J., Schnapp, B.J.,
buffer, immune complexes were analyzed by SDS-PAGE and immu- Rapoport, T.A., and Margolis, B. (2001). Cargo of kinesin identi-
noblotting. Metabolic labeling, phosphorylation site mapping, and fied as JIP scaffolding proteins and associated signaling mole-
indirect immunofluorescent staining were performed as previously cules. J. Cell Biol. 152, 959–970.
described [4]. 15. Luttrell, L.M., and Lefkowitz, R.J. (2002). The role of beta-
arrestins in the termination and transduction of G-protein-cou-
pled receptor signals. J. Cell Sci. 115, 455–465.In Vitro Raf Kinase Assay
Raf-1 immunoprecipitates were washed extensively with 1% NP-40 16. Teis, D., Wunderlich, W., and Huber, L.A. (2002). Localization
of the MP1-MAPK scaffold complex to endosomes is mediatedbuffer. The immune complexes were then incubated in 40 l kinase
buffer (100 mM Tris [pH 7.4], 25 mM -glycerophosphate, 5 mM by p14 and required for signal transduction. Dev. Cell 3,
803–814.EGTA, 1 mM DTT, 1 mM Na3VO4, 60 M ATP, 10 mM MnCl2) con-
taining 20 Ci of [-32P]ATP and 0.1 g of purified kinase-inactive 17. Cacace, A.M., Michaud, N.R., Therrien, M., Mathes, K., Cope-
land, T., Rubin, G.M., and Morrison, D.K. (1999). IdentificationMEK. After incubation for 30 min at 25C, reactions were stopped
Current Biology
1364
of constitutive and ras-inducible phosphorylation sites of KSR: (1996). KSR modulates signal propagation within the MAPK cas-
cade. Genes Dev. 10, 2684–2695.implications for 14-3-3 binding, mitogen-activated protein ki-
nase binding, and KSR overexpression. Mol. Cell. Biol. 19, 37. Laird, A.D., Morrison, D.K., and Shalloway, D. (1999). Character-
ization of Raf-1 activation in mitosis. J. Biol. Chem. 274, 4430–229–240.
18. Xing, H., Kornfeld, K., and Muslin, A.J. (1997). The protein kinase 4439.
38. Wilm, M., Shevchenko, A., Houthaeve, T., Breit, S., Schweigerer,KSR interacts with 14-3-3 protein and Raf. Curr. Biol. 7, 294–300.
19. Zhou, M., Horita, D.A., Waugh, D.S., Byrd, R.A., and Morrison, L., Fotsis, T., and Mann, M. (1996). Femtomole sequencing of
proteins from polyacrylamide gels by nano-electrospray massD.K. (2002). Solution structure and functional analysis of the
cysteine-rich C1 domain of kinase suppressor of Ras (KSR). J. spectrometry. Nature 379, 466–469.
Mol. Biol. 315, 435–446.
20. Jacobs, D., Glossip, D., Xing, H., Muslin, A.J., and Kornfeld,
K. (1999). Multiple docking sites on substrate proteins form a
modular system that mediates recognition by ERK MAP kinase.
Genes Dev. 13, 163–175.
21. Stewart, S., Sundaram, M., Zhang, Y., Lee, J., Han, M., and
Guan, K.L. (1999). Kinase suppressor of Ras forms a multiprotein
signaling complex and modulates MEK localization. Mol. Cell.
Biol. 19, 5523–5534.
22. Nguyen, A., Burack, W.R., Stock, J.L., Kortum, R., Chaika, O.V.,
Afkarian, M., Muller, W.J., Murphy, K.M., Morrison, D.K., Lewis,
R.E., et al. (2002). Kinase suppressor of Ras (KSR) is a scaffold
which facilitates mitogen- activated protein kinase activation in
vivo. Mol. Cell. Biol. 22, 3035–3045.
23. Janssens, V., and Goris, J. (2001). Protein phosphatase 2A: a
highly regulated family of serine/threonine phosphatases impli-
cated in cell growth and signalling. Biochem. J. 353, 417–439.
24. Volle, D.J., Fulton, J.A., Chaika, O.V., McDermott, K., Huang,
H., Steinke, L.A., and Lewis, R.E. (1999). Phosphorylation of the
kinase suppressor of ras by associated kinases. Biochemistry
38, 5130–5137.
25. Favre, B., Turowski, P., and Hemmings, B.A. (1997). Differential
inhibition and posttranslational modification of protein phos-
phatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic
acid, and tautomycin. J. Biol. Chem. 272, 13856–13863.
26. Abraham, D., Podar, K., Pacher, M., Kubicek, M., Welzel, N.,
Hemmings, B.A., Dilworth, S.M., Mischak, H., Kolch, W., and
Baccarini, M. (2000). Raf-1-associated protein phosphatase 2A
as a positive regulator of kinase activation. J. Biol. Chem. 275,
22300–22304.
27. Jaumot, M., and Hancock, J.F. (2001). Protein phosphatases 1
and 2A promote Raf-1 activation by regulating 14-3-3 interac-
tions. Oncogene 20, 3949–3958.
28. Dhillon, A.S., Meikle, S., Yazici, Z., Eulitz, M., and Kolch, W.
(2002). Regulation of Raf-1 activation and signalling by dephos-
phorylation. EMBO J. 21, 64–71.
29. Wassarman, D.A., Solomon, N.M., Chang, H.C., Karim, F.D.,
Therrien, M., and Rubin, G.M. (1996). Protein phosphatase 2A
positively and negatively regulates Ras1- mediated photorecep-
tor development in Drosophila. Genes Dev. 10, 272–278.
30. Sieburth, D.S., Sundaram, M., Howard, R.M., and Han, M. (1999).
A PP2A regulatory subunit positively regulates Ras-mediated
signaling during Caenorhabditis elegans vulval induction. Genes
Dev. 13, 2562–2569.
31. Frost, J.A., Alberts, A.S., Sontag, E., Guan, K., Mumby, M.C.,
and Feramisco, J.R. (1994). Simian virus 40 small t antigen coop-
erates with mitogen-activated kinases to stimulate AP-1 activity.
Mol. Cell. Biol. 14, 6244–6252.
32. Zhou, B., Wang, Z.X., Zhao, Y., Brautigan, D.L., and Zhang, Z.Y.
(2002). The specificity of extracellular signal-regulated kinase 2
dephosphorylation by protein phosphatases. J. Biol. Chem. 277,
31818–31825.
33. Sontag, E., Fedorov, S., Kamibayashi, C., Robbins, D., Cobb,
M., and Mumby, M. (1993). The interaction of SV40 small tumor
antigen with protein phosphatase 2A stimulates the map kinase
pathway and induces cell proliferation. Cell 75, 887–897.
34. Alessi, D.R., Gomez, N., Moorhead, G., Lewis, T., Keyse, S.M.,
and Cohen, P. (1995). Inactivation of p42 MAP kinase by protein
phosphatase 2A and a protein tyrosine phosphatase, but not
CL100, in various cell lines. Curr. Biol. 5, 283–295.
35. Silverstein, A.M., Barrow, C.A., Davis, A.J., and Mumby, M.C.
(2002). Actions of PP2A on the MAP kinase pathway and apo-
ptosis are mediated by distinct regulatory subunits. Proc. Natl.
Acad. Sci. USA 99, 4221–4226.
36. Therrien, M., Michaud, N.R., Rubin, G.M., and Morrison, D.K.
